BRTX
BioRestorative Therapies, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.15
+2.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.35x
- Price / sales
- 11.42x
- Price / cash flow
- -0.35x
Enterprise value
- Enterprise value
- $530.6K
- EV / sales
- 1.48x
- EV / EBITDA
- -0.05x
- EV / EBIT
- -0.04x
- Market cap
- $4.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026